Research could solve prostate cancer controversy

November 20, 2013

New research led by Dr. Rodney Breau is shedding light on a major controversy around how best to treat prostate cancer patients who have had their prostates removed. While some studies suggest that no follow-up treatment is required, others have suggested benefits from radiation therapy or hormone therapy. A survey by Dr. Breau and his colleagues revealed stark differences in how urologists and radiation oncologists interpret this evidence, with radiation oncologists being nearly 50% more likely to recommend radiation to their patients. See PLOS ONE for details.

Prostate cancer patients at The Ottawa Hospital can participate in a major clinical trial that is expected to solve this controversy and ensure that patients around the world receive consistent advice and the best possible follow-up care.

About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.

Media contact
Jennifer Ganton
Director, Communications and Public Relations
Ottawa Hospital Research Institute
613-798-5555 x 73325
613-614-5253 (cell)